Core Insights - Carvana reported $4.23 billion in revenue for Q1 2025, a year-over-year increase of 38.3% and an EPS of $1.51 compared to -$0.41 a year ago, exceeding Zacks Consensus Estimates for revenue and EPS [1] - The company has shown strong stock performance, with shares returning +46.8% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change, and currently holds a Zacks Rank 1 (Strong Buy) [3] Financial Performance Metrics - Retail vehicle unit sales reached 133,898, surpassing the six-analyst average estimate of 129,401 [4] - Retail vehicle sales, net, amounted to $2.98 billion, exceeding the four-analyst average estimate of $2.88 billion, representing a year-over-year change of +37% [4] - Wholesale sales and revenues were reported at $863 million, above the estimated $804.95 million, reflecting a +31.4% change year-over-year [4] - Other sales and revenues totaled $389 million, exceeding the estimated $339.14 million, with a significant year-over-year increase of +69.9% [4] Profitability Metrics - Per retail unit gross profit totaled $6,938, slightly below the estimated $6,956.18 [4] - Per retail unit gross profit for retail vehicles was $3,204, compared to the average estimate of $3,350.74 [4] - Per unit revenue for retail vehicles was $22,256, lower than the estimated $22,762.43 [4]

Core Insights - Healthpeak reported revenue of $702.89 million for the quarter ended March 2025, reflecting a year-over-year increase of 15.9% and a surprise of +0.98% over the Zacks Consensus Estimate of $696.06 million [1] - The company's EPS for the quarter was $0.46, which is a significant increase from $0.01 in the same quarter last year, aligning with the consensus EPS estimate [1] Revenue Breakdown - Resident fees and services generated $148.93 million, slightly above the average estimate of $147.18 million from three analysts [4] - Rental and related revenues amounted to $538.14 million, exceeding the average estimate of $527.49 million from three analysts, representing a year-over-year change of +16.5% [4] - Interest income and other revenues were reported at $15.82 million, below the estimated $16.97 million, but showed a substantial year-over-year increase of +175.1% [4] Stock Performance - Healthpeak's shares have returned -7.3% over the past month, compared to a -5.1% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance. For the quarter ended March 2025, Carter Bankshares, Inc. (CARE) reported revenue of $37.22 million, up 11.2% over the same period last year. EPS came in at $0.32, compared to $0.24 in the year-ago quarter. The reported revenue represents a surprise of +6.92% over the Zacks Consensus Es ...